1. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy. (13th June 2020) Authors: Messadeg, L; Hordonneau, C; Bouguen, G; Goutorbe, F; Reimund, J M; Goutte, M; Boucher, A L; Scanzi, J; Reymond, M; Allimant, C; Dapoigny, M; Pereira, B; Bommelaer, G; Buisson, A Journal: Journal of Crohn's and colitis Issue: Volume 14:Number 11(2020) Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P304 Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn's disease. (16th January 2018) Authors: Allimant, C; Messadeg, L; Minet Quinard, R; Goutte, M; Bouvier, D; Goutorbe, F; Pereira, B; Bommelaer, G; Hordonneau, C; Buisson, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗